Donna M Bilder

Title: Donna M Bilder: Innovator in HIV Research

Introduction

Donna M Bilder is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit HIV reverse transcriptase. With a total of 2 patents to her name, her work has the potential to impact the treatment of viral infections.

Latest Patents

Among her latest patents, one notable invention is titled "Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazepine as HIV reverse transcriptase inhibitors." This invention relates to 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones, which are useful as inhibitors of HIV reverse transcriptase. The patent outlines pharmaceutical compositions and diagnostic kits that utilize these compounds for treating viral infections or as assay standards or reagents. Another significant patent is "1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors," which further explores the applications of these compounds in combating HIV.

Career Highlights

Donna has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Pharma Company and DuPont Pharmaceuticals Company. Her experience in these organizations has allowed her to develop her expertise in drug discovery and development.

Collaborations

Throughout her career, Donna has collaborated with esteemed colleagues such as James David Rodgers and Anthony J Cocuzza. These partnerships have contributed to her innovative research and the advancement of her patents.

Conclusion

Donna M Bilder is a dedicated inventor whose work in HIV research has led to valuable patents that may enhance treatment options for viral infections. Her contributions to the pharmaceutical field continue to be significant and impactful.